马瑜婷，研究员，博士生导师，系统院执行副院长。曾获江苏省自然科学一等奖、中国青年女科学家奖、钟南山青年科技创新奖、中国青年五四奖章、全国先进工作者、国务院政府特殊津贴等；入选中共二十大代表；入选国家万人计划领军人才、国家海外高层次人才等；获科技创新2030重大、国自然青B等项目资助。
     中国足球彩票：2015年引进人才，曾在法国国家健康与医学研究院、古斯塔夫鲁西研究所、巴黎第五大学科德利埃研究中心完成博士后工作。

长期开展应激重塑免疫景观的研究，提出“多重应激的免疫识别和调控”新理论，助力免疫治疗新靶点和老药新用策略的挖掘开发，承担国家和省部级科研课题19项，在Nat Med、Nat Rev Immunol、Science等期刊发表论文60余篇，H指数40，入选全球前2%顶尖科学家，参编中英文专著5部，培养硕博士研究生20余名，担任中国免疫学会理事、中国生物医学工程学会常务理事等，是多个学术期刊资深副主编或编委。

中国足球彩票

1.Qin S#, Yang Y#, Wang H#, Li M#, Deng Y, Chen Y, Li C, Peng L, Xu L, Qiu X, Guan Y, Wang S, He Y, Wang X*, Ma Y*, Huang L*, Chen D*. scBrainScope: cross-species multidimensional brain atlas. Nucleic Acids Res. 2025 Nov 17:gkaf1092. (IF= 13.1)

2.Li P#, Liang M#, Zhu J#, Chen J#, Xia L, Jin Z, Zhang X, Zhang S, Wang Q, Liu Z, Ping Y, Wang Z, Wong CC, Zhang Y, Yang H, Ye Z, Ma Y*. Elevated activity of plasma dipeptidyl peptidase 4 upon stress can be targeted to reverse tumor immunosuppression. Pharmacol Res. 2025, 215:107696. (IF=10.5)

3.Ma Y#*, Kroemer G. The cancer-immune dialogue in the context of stress. Nat Rev Immunol. 2024, 24(4):264-281. (IF= 67.7)

4.Chen J#, Jin Z, Zhang S, Zhang X, Li P, Yang H, Ma Y*. Arsenic trioxide elicits prophylactic and therapeutic immune responses against solid tumors by inducing necroptosis and ferroptosis. Cell Mol Immunol 2023, 20(1):51-64. (IF= 21.8)

5.Ma Y#*. Tpt1 the balance toward immunosuppression upon cell death. Nat Immunol. 2021, 22(8):940-942. (IF= 27.8)

6.Yang H#, Xia L#, Chen J#, Zhang S, Martin V, Li Q, Lin S, Chen J, Calmette J, Lu M, Fu L, Yang J, Pan Z, Yu K, He J, Morand E, Schlecht-Louf G, Krzysiek R, Zitvogel L, Kang B, Zhang Z, Leader A, Zhou P, Lanfumey L, Shi M, Kroemer G*, Ma Y*. Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity. Nat Med. 2019, 25(9):1428-1441. (IF= 58.7, C100, F1000)

7.Yang H, Yamazaki T, Pietrocola F, Zhou H, Zitvogel L, Ma Y*, Kroemer G*. STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells. Cancer Res.2015, 15;75(18):3812-22. (IF= 9.088)

8.Vacchelli E#, Ma Y#, Baracco EE, Sistigu A, Enot DP, Pietrocola F, Yang H, Adjemian S, Chaba K, Semeraro M, Signore M, De Ninno A, Lucarini V, Peschiaroli F, Businaro L, Gerardino A, Manic G, Ulas T, Günther P, Schultze JL, Kepp O, Stoll G, Lefebvre C, Mulot C, Castoldi F, Rusakiewicz S, Ladoire S, Apetoh L, Bravo-San Pedro JM, Lucattelli M, Delarasse C, Boige V, Ducreux M, Delaloge S, Borg C, André F, Schiavoni G, Vitale I, Laurent-Puig P, Mattei F, Zitvogel L*, Kroemer G*. Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1. Science. 2015, 20;350(6263):972-8. (IF= 44.7, C100, F1000)

9.Ma Y#, Adjemian S#, Mattarollo SR, Yamazaki T, Aymeric L, Yang H, Portela Catani JP, Hannani D, Duret H, Steegh K, Martins I, Schlemmer F, Michaud M, Kepp O, Sukkurwala AQ, Menger L, Vacchelli E, Droin N, Galluzzi L, Krzysiek R, Gordon S, Taylor PR, Van Endert P, Solary E, Smyth MJ, Zitvogel L*, Kroemer G*. Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells. Immunity. 2013, 18;38(4):729-41. (IF=21.884, ESI, C100)

10.Ma Y#, Aymeric L, Locher C, Mattarollo SR, Delahaye NF, Pereira P, Boucontet L, Apetoh L, Ghiringhelli F, Casares N, Lasarte JJ, Matsuzaki G, Ikuta K, Ryffel B, Benlagha K, Tesnière A, Ibrahim N, Déchanet-Merville J, Chaput N, Smyth MJ, Kroemer G*, Zitvogel L*. Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy. J Exp Med. 2011, 208(3):491-503. (IF= 10.6, C100)